Metrion Biosciences’ Senior Scientist Dr Edward Humphries will be attending and presenting a talk at the Sophion EU User meeting to be held on Thursday 5th and Friday 6th September 2019 in Copenhagen. The title of Edd’s presentation is: “Recent drug discovery applications run on QPatch in CRO collaborative mode”
Sophion EU User Meeting
September 5, 2019 @ 8:00 am - September 6, 2019 @ 5:00 pm
Edd will also be available for the duration of the meeting to provide an overview of Metrion’s ion channel screening services and to answer any questions regarding our assays and services.
Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge biocluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from one-off screening projects to fully integrated drug discovery programmes delivering clinical candidates.